Global Product Portfolio
Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical products.
Please note: Not all treatments are available in all countries.
capmatinib
carbamazepine
Tegretol®
carbamazepine
Neuroscience
Established Medicines
dabrafenib
Tafinlar®
dabrafenib
Oncology
Oncology
dexamethasone
Tobradex®
tobramycin, dexamethasone
Ophthalmology
Ophthalmology
lapatinib
Tyverb®
lapatinib
Oncology
Oncology
nilotinib
Tasigna®
nilotinib
Oncology
Oncology
oxcarbazepine
Trileptal®
oxcarbazepine
Neuroscience
Established Medicines
tobramycin
TOBI®
tobramycin
Respiratory
Established Medicines
TOBI® Podhaler™
tobramycin
Respiratory
Established Medicines
Tobradex®
tobramycin, dexamethasone
Ophthalmology
Ophthalmology
travoprost
Travatan Z®
travoprost
Ophthalmology
Ophthalmology
Travatan®
travoprost
Ophthalmology
Ophthalmology
Travatan® BAK-Free
travoprost
Ophthalmology
Ophthalmology